← Open Payments lookup

SELMAN MANUEL: Open Payments

NPI 1992170427 · TUKWILA, WA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$786 in 19 payments from 7 companies in 2025. Trend: 2023 $99 · 2024 $367 · 2025 $786

Food & beverage: $786
CompanyPaymentsAmount
Novo Nordisk Inc4$308
ABBVIE INC.9$196
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$179
Vanda Pharmaceuticals Inc.1$32
Alkermes, Inc.1$24
Otsuka America Pharmaceutical, Inc.1$24
Salix Pharmaceuticals, a division of Bausch Health US, LLC1$23

Products named: VRAYLAR, CAPLYTA, Wegovy, Ozempic, FANAPT, ARISTADA, REXULTI, XIFAXAN.

Industry payments across WA — which companies pay providers there.